[1]
RAVI SHANKAR et al. 2024. ROLE OF ANTIOXIDANT AND INFLAMMATORY MARKERS WITH METABOLIC SYNDROME AND RISK OF CVD IN THYROID PATIENTS. Asian Journal of Pharmaceutical and Clinical Research. 17, 7 (Jul. 2024), 153–158. DOI:https://doi.org/10.22159/ajpcr.2024v17i7.51845.